JP2010522713A5 - - Google Patents

Download PDF

Info

Publication number
JP2010522713A5
JP2010522713A5 JP2010500259A JP2010500259A JP2010522713A5 JP 2010522713 A5 JP2010522713 A5 JP 2010522713A5 JP 2010500259 A JP2010500259 A JP 2010500259A JP 2010500259 A JP2010500259 A JP 2010500259A JP 2010522713 A5 JP2010522713 A5 JP 2010522713A5
Authority
JP
Japan
Prior art keywords
group
alkyl
atom
ring
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010500259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010522713A (ja
JP5397959B2 (ja
Filing date
Publication date
Priority claimed from EP07105053A external-priority patent/EP1975165A1/de
Application filed filed Critical
Publication of JP2010522713A publication Critical patent/JP2010522713A/ja
Publication of JP2010522713A5 publication Critical patent/JP2010522713A5/ja
Application granted granted Critical
Publication of JP5397959B2 publication Critical patent/JP5397959B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010500259A 2007-03-27 2008-03-26 置換ピロリジンアミド、それの製造方法、及び、それの薬剤としての使用 Expired - Fee Related JP5397959B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105053.8 2007-03-27
EP07105053A EP1975165A1 (de) 2007-03-27 2007-03-27 Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2008/053568 WO2008116881A1 (de) 2007-03-27 2008-03-26 Substituierte pyrrolidinamide, deren herstellung und deren verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
JP2010522713A JP2010522713A (ja) 2010-07-08
JP2010522713A5 true JP2010522713A5 (https=) 2011-05-12
JP5397959B2 JP5397959B2 (ja) 2014-01-22

Family

ID=38599360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010500259A Expired - Fee Related JP5397959B2 (ja) 2007-03-27 2008-03-26 置換ピロリジンアミド、それの製造方法、及び、それの薬剤としての使用

Country Status (10)

Country Link
US (1) US8309542B2 (https=)
EP (2) EP1975165A1 (https=)
JP (1) JP5397959B2 (https=)
AR (1) AR065852A1 (https=)
CA (1) CA2682012A1 (https=)
CL (1) CL2008000873A1 (https=)
PE (1) PE20090226A1 (https=)
TW (1) TW200902022A (https=)
UY (1) UY30979A1 (https=)
WO (1) WO2008116881A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741890B2 (en) 2007-11-15 2014-06-03 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
CN102066321A (zh) * 2008-06-16 2011-05-18 弗·哈夫曼-拉罗切有限公司 作为nk2受体拮抗剂的吡咯烷衍生物
MX2012002898A (es) * 2009-09-11 2012-04-02 Sunovion Pharmaceuticals Inc Agonistas y antagonistas inversos de histamina h3 y metodos de uso para los mismos.
IN2014DN09346A (https=) 2012-06-13 2015-07-17 Hoffmann La Roche
KR102179599B1 (ko) 2012-09-25 2020-11-19 에프. 호프만-라 로슈 아게 이환형 유도체
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
CN105764905B (zh) 2013-11-26 2019-06-07 豪夫迈·罗氏有限公司 新的八氢-环丁二烯并[1,2-c;3,4-c’]二吡咯-2基
WO2015144609A1 (en) 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
CA2960277A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Substituted pyrrolidine carboxamide compounds
EP3078378B1 (en) 2015-04-08 2020-06-24 Vaiomer Use of factor xa inhibitors for regulating glycemia
CA2992889A1 (en) 2015-09-04 2017-03-09 F. Hoffmann-La Roche Ag Phenoxymethyl derivatives
CR20180057A (es) 2015-09-24 2018-04-02 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de atx/ca.
AU2016328365B2 (en) 2015-09-24 2020-04-23 F. Hoffmann-La Roche Ag New bicyclic compounds as dual ATX/CA inhibitors
KR20180054830A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 오토탁신(atx) 억제제로서의 이환형 화합물
RU2018112230A (ru) 2015-09-24 2019-10-30 Ф. Хоффманн-Ля Рош Аг Бициклические соединения в качестве ингибиторов atx
CA3043938A1 (en) 2016-12-21 2018-06-28 Biotheryx, Inc. Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
SG11201908560SA (en) 2017-03-16 2019-10-30 Hoffmann La Roche Heterocyclic compounds useful as dual atx/ca inhibitors
EP3920885A1 (en) 2019-02-08 2021-12-15 Frequency Therapeutics, Inc. Valproic acid compounds and wnt agonists for treating ear disorders
PE20220572A1 (es) * 2019-04-30 2022-04-20 Calico Life Sciences Llc Moduladores de la via integrada del estres
KR102333564B1 (ko) * 2019-11-28 2021-12-01 동방에프티엘(주) 광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE308540T1 (de) * 2000-08-17 2005-11-15 Lilly Co Eli Antithrombosemittel
US7312214B2 (en) * 2002-05-10 2007-12-25 Bristol-Myers Squibb Company 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors
KR101050700B1 (ko) * 2002-08-26 2011-07-20 다케다 야쿠힌 고교 가부시키가이샤 칼슘 수용체 조절 화합물 및 이의 용도
US7205318B2 (en) * 2003-03-18 2007-04-17 Bristol-Myers Squibb Company Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
US7820699B2 (en) 2005-04-27 2010-10-26 Hoffmann-La Roche Inc. Cyclic amines
PE20070171A1 (es) 2005-06-30 2007-03-08 Boehringer Ingelheim Int GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa
US20070032473A1 (en) 2005-07-19 2007-02-08 Kai Gerlach Substituted amides and their use as medicaments
EP1818330A1 (de) * 2006-02-14 2007-08-15 Boehringer Ingelheim Pharma GmbH & Co.KG Substituierte Prolinamide, deren Herstellung und deren Verwendung als Arzneimittel
MY146623A (en) * 2006-05-16 2012-09-14 Boehringer Ingelheim Int Substituted prolinamides, manufacturing, and the use thereof as medicaments

Similar Documents

Publication Publication Date Title
JP2010522713A5 (https=)
JP2009537483A5 (https=)
ES2655899T3 (es) Compuestos de pirazolo[1,5-a]pirimidina sustituidos como inhibidores de la Trk cinasa
RU2386622C2 (ru) Гетероароматические производные мочевины и их применение в качестве активаторов глюкокиназы
JP2013522286A5 (https=)
JP2020033357A5 (https=)
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
JP2002509908A5 (https=)
NO20063340L (no) Pyrazol-[3,4-B]-pyridinforbindelser, og deres anvendelse som fosfodiesteraseinhibitorer
NO20062633L (no) Pyrazolderivater som proteinkinasemodulatorer
JP2013509442A5 (https=)
DE602004011401D1 (de) Benzazepinderivate als histamin-h3-antagonisten
AR061793A1 (es) Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
JP2009532375A5 (https=)
JP2010504286A5 (https=)
JP2016501185A5 (https=)
RU2010137115A (ru) Производные 5,6-бисарил-2-пиридинкарбоксамидов, способ их получения и их применение в терапии в качестве антагонистов рецепторов
ATE501141T1 (de) Kondensierte bizyklisch substituierte amine als histamin 3 rezeptor liganden
RU2013157860A (ru) Производные бензотиазинтиона, способы их получения и применение
MY157481A (en) Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors
JP2016527184A5 (https=)
FI3911631T3 (fi) Uusia substituoituja sulfonyyliureajohdannaisia
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
RU2008136754A (ru) Замещенные пролинамиды, их получение и их применение в качестве лекарственных средств
RU2006133258A (ru) Замещенные азетидиновые производные, их получение и применение в качестве лекарственных средств